← Every company
Vertex Pharmaceuticals Inc Lobbying
What Vertex Pharmaceuticals Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
VRTX on carbonthat →Disclosed spend
$3.3M
across every filing on file
Filings
25
Years covered
1
Firms retained
4
What it lobbies about
PharmacyHealth IssuesMedicare/MedicaidTaxation/Internal Revenue CodeBudget/AppropriationsTrade (domestic/foreign)
25 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20262nd Quarter (Apr 1 - June 30) | VERTEX PHARMACEUTICALS INCORPORATEDHealth IssuesMedicare/Medicaid | $1.2M |
| 20261st Quarter (Jan 1 - Mar 31) | VERTEX PHARMACEUTICALS INCORPORATEDHealth IssuesMedicare/Medicaid | $1.1M |
| 20261st Quarter (Jan 1 - Mar 31) | TARPLIN, DOWNS & YOUNG, LLCBudget/AppropriationsHealth Issues | $80K |
| 20262nd Quarter (Apr 1 - June 30) | TARPLIN, DOWNS & YOUNG, LLCBudget/AppropriationsHealth Issues | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | CGCN GROUP, LLCHealth IssuesMedicare/Medicaid | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK HEALTH STRATEGIES, INC. | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK GROUPHealth IssuesDefense | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | AVENUE SOLUTIONSHealth IssuesMedicare/Medicaid | $60K |
| 20262nd Quarter (Apr 1 - June 30) | TIBER CREEK HEALTH STRATEGIES, INC. | $60K |
| 20262nd Quarter (Apr 1 - June 30) | MARSHALL & POPP, LLCMedicare/MedicaidTrade (domestic/foreign) | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | MARSHALL & POPP, LLCMedicare/Medicaid | $60K |
| 20262nd Quarter (Apr 1 - June 30) | EMPIRE CONSULTING GROUPHealth Issues | $50K |
| 20262nd Quarter (Apr 1 - June 30) | ALB SOLUTIONSPharmacy | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | STANTON PARK GROUPHealth Issues | $50K |
| 20262nd Quarter (Apr 1 - June 30) | CROSSROADS STRATEGIES, LLCHealth IssuesMedical/Disease Research/Clinical Labs | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | ALB SOLUTIONSPharmacy | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | EMPIRE CONSULTING GROUPHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | CROSSROADS STRATEGIES, LLCMedical/Disease Research/Clinical LabsHealth Issues | $30K |
| 20261st Quarter (Jan 1 - Mar 31) | HOLLAND & KNIGHT LLPTaxation/Internal Revenue Code | $20K |
| 20261st Quarter (Jan 1 - Mar 31) | ALSTON & BIRD LLPBudget/AppropriationsHealth Issues | $20K |
| 20262nd Quarter (Apr 1 - June 30) | HOLLAND & KNIGHT LLPTaxation/Internal Revenue Code | $20K |
| 20261st Quarter (Jan 1 - Mar 31) | SALT POINT STRATEGIESPharmacy | $10K |
| 20261st Quarter (Jan 1 - Mar 31) | ALB SOLUTIONSPharmacy | — |
| 20261st Quarter (Jan 1 - Mar 31) | MCLARTY INBOUND LLC | — |
| 20261st Quarter (Jan 1 - Mar 31) | ALSTON & BIRD LLPBudget/AppropriationsHealth Issues | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on VRTX
Company overviewEverything on VRTX in one place, with the price.SEC filingsWhat VRTX's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat VRTX's own officers and directors buy and sell.Who owns itEvery manager reporting a position in VRTX.Funds holding itWhich funds and ETFs hold VRTX, and how big a bet.Who lobbies for itThe lobbyists on VRTX's account, and who they worked for.PatentsWhat VRTX is filing at the patent office.